Related Experiment Video
Updated: Jan 29, 2026
04:36
Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
2.6K
Hepatitis C Infection in Hemodialysis Patients.
D C Caragea1, A R Mihailovici2, C T Streba3
1Department of Nephrology, University of Medicine and Pharmacy of Craiova, Romania.
Current Health Sciences Journal
|February 13, 2019
Summary
Hepatitis C virus (HCV) infection remains a significant concern for hemodialysis patients, with prevalence varying across Europe. While some regions show decreasing trends, others, like Romania, face persistently high rates, often linked to nosocomial transmission.
Area of Science:
- Nephrology
- Infectious Diseases
- Hepatology
Background:
- Hepatitis C virus (HCV) infection is a major cause of morbidity and mortality in renal transplant and hemodialysis patients.
- While European trends suggest a decrease in HCV incidence and prevalence among hemodialysis patients, regional variations persist.
- HCV prevalence in hemodialysis patients is generally higher than in the general population.
Purpose of the Study:
- To analyze the current epidemiological trends of hepatitis C virus infection in hemodialysis patients across Europe.
- To identify factors contributing to persistent high HCV prevalence and incidence in specific regions, such as Romania.
- To evaluate the effectiveness of current control measures and recommend improvements.
Main Methods:
- Review of epidemiological data on HCV infection in European hemodialysis centers.
- Analysis of regional variations in HCV incidence and prevalence over the past decade.
- Identification of primary transmission routes, with a focus on nosocomial infections.
Main Results:
- A general European trend towards decreasing HCV incidence and prevalence in hemodialysis patients is observed.
- Significant regional disparities exist, with some countries maintaining high infection rates.
- In Romania, high HCV prevalence and incidence are linked to nosocomial transmission, potentially exacerbated by resource limitations.
Conclusions:
- Hepatitis C virus infection control in hemodialysis requires tailored regional strategies.
- Enhanced isolation measures are recommended for dialysis centers with high HCV prevalence.
- Addressing nosocomial transmission is crucial, especially in resource-limited settings with growing dialysis populations.
Related Concept Videos
01:25Hemodialysis I: Introduction
1.6K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.6K
01:24Hemodialysis II: Procedure and Complications
790
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
790
01:25Hemodialysis III: Nursing Management
843
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
843
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
274
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
274
01:21Hepatic Portal System
5.8K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.8K
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
502
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
502